Screener
Bioventus BVS International Segment — Adjusted selling expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept bvs:SellingExpenseAdjusted.
The source filing: Bioventus’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
FAQ
- What is Bioventus's international segment — adjusted selling expense?
- Bioventus (BVS) reported international segment — adjusted selling expense of $3.39M in Q2 2026.
- How has Bioventus's international segment — adjusted selling expense changed year-over-year?
- Bioventus's international segment — adjusted selling expense increased by 5.3% year-over-year, from $3.22M to $3.39M.
- What is the long-term trend for Bioventus's international segment — adjusted selling expense?
- Over 3 years (2022 to 2025), Bioventus's international segment — adjusted selling expense has grown at a 4.0% compound annual growth rate (CAGR), from $11.29M to $12.69M.
- What does international segment — adjusted selling expense mean?
- Captures the adjusted costs incurred by the sales force and distribution teams dedicated to the international segment. It provides insight into the investment required to maintain and expand market share in foreign territories.
Ask your AI about Bioventus's international segment — adjusted selling expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude